Na+/K+-
ATPase functions as both an
ion pump and a signal transducer.
Cardiac glycosides partially inhibit Na+/K+-
ATPase, causing activation of multiple interrelated growth pathways via the Na+/K+-
ATPase/c-Src/
epidermal growth factor receptor complex. Such pathways include Ras/
MEK/ERK and Ral/
RalGDS cascades, which can lead to
cardiac hypertrophy. In search of novel Ral-
GTPase binding proteins, we used RalB as the bait to screen a human testes
cDNA expression library using the yeast 2-hybrid system. The results demonstrated that 1 of the RalB interacting clones represented the C-terminal region of the beta1 subunit of Na+/K+-
ATPase. Further analysis using the yeast 2-hybrid system and full-length beta1 subunit of Na+/K+-
ATPase confirmed the interaction with RalA and RalB. In vitro binding and pull-down assays demonstrated that the beta1 subunit of Na+/K+-
ATPase interacts directly with RalA and RalB. Ral-
GTP pull-down assays demonstrated that short-term
ouabain treatment of A7r5 cells, a rat aorta smooth muscle cell line, caused activation of Ral
GTPase. Maximal activation was observed 10 min after
ouabain treatment.
Ouabain-mediated Ral activation was inhibited upon the stimulation of Na+/K+-
ATPase activity by Ang II. We propose that Ral
GTPase is involved in the signal transducing function of Na+/K+-
ATPase and provides a possible molecular mechanism connecting Ral to
cardiac hypertrophy during diseased conditions.